Magali Farella

Monitoring of <i>KRAS</i>-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma

Nicolas Guibert, Julien Mazières, Myriam Delaunay et al. · Oncotarget · 2017 · 88 citations · Full text

Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS -mutated lung adenocarcinoma

Nicolas Guibert, Anne Pradines, Magali Farella et al. · Lung Cancer · 2016 · 61 citations

Kras Mutations, Oncology, Cancer Detection +11

The <scp>RAS</scp> ‐related <scp>GTP</scp> ase <scp>RHOB</scp> confers resistance to <scp>EGFR</scp> ‐tyrosine kinase inhibitors in non‐small‐cell lung cancer via an <scp>AKT</scp> ‐dependent mechanism

Olivier Calvayrac, Julien Mazières, Sarah Figarol et al. · EMBO Molecular Medicine · 2016 · 36 citations · Full text

Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF -Mutated Lung Adenocarcinoma

Nicolas Guibert, Anne Pradines, Anne Casanova et al. · Journal of Thoracic Oncology · 2016 · 35 citations · Full text

Oncology, Braf Mutation, Somatic Variant +11

Baseline circulating myeloid-derived suppressor cells and response to PD-1 inhibitor in non-small cell lung cancer patients.

Myriam Delaunay, Nicolas Guibert, Amellie Lusque et al. · Journal of Clinical Oncology · 2018 · 11 citations

Immunology, Immunoediting, Pathology +19